LivaNova (LIVN) Interest Coverage Ratio Growth (1y) (2015 - 2026)
LivaNova (LIVN) Interest Coverage Ratio Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.85 Bn | 194.25 Bn | 7.27 Bn | -71.56% |
| 2 | Stryker | 129.75 Bn | 126.28 Bn | 4.50 Bn | 68.09% |
| 3 | Medtronic | 119.86 Bn | 110.64 Bn | 6.41 Bn | 28.95% |
| 4 | Boston Scientific | 74.04 Bn | 73.50 Bn | 3.85 Bn | 34.84% |
| 5 | Edwards Lifesciences | 52.51 Bn | 48.26 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.75 Bn | 32.81 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.16 Bn | 32.05 Bn | 2.18 Bn | 12.01% |
| 8 | Koninklijke Philips | 26.43 Bn | 23.11 Bn | 4.55 Bn | -29.36% |
| 9 | Steris | 23.26 Bn | 22.78 Bn | 684.20 Mn | 16.91% |
| 10 | LivaNova | 4.32 Bn | 3.81 Bn | 273.67 Mn | 90.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -77.31% |
| Mar 31, 2026 | -79.88% |
| Dec 31, 2025 | -346.35% |
| Sep 30, 2025 | 121.65% |
| Jun 30, 2025 | 70.62% |
| Mar 31, 2025 | 211.14% |
| Dec 31, 2024 | 141.68% |
| Sep 30, 2024 | 654.08% |
| Jun 30, 2024 | 120.40% |
| Mar 31, 2024 | 686.48% |
| Dec 31, 2023 | -639.11% |
| Sep 30, 2023 | 102.85% |
| Jun 30, 2023 | -46.84% |
| Mar 31, 2023 | -114.38% |
| Dec 31, 2022 | -73.22% |
| Sep 30, 2022 | -820.74% |
| Jun 30, 2022 | 200.52% |
| Mar 31, 2022 | 439.07% |
| Dec 31, 2021 | 124.44% |
| Sep 30, 2021 | 380.99% |